Immunogenicity of a Single Dose of GSK Biologicals' Diphtheria, Tetanus and Acellular Pertussis (dTpa) Booster Vaccine (Boostrix ) in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2018
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 15 Feb 2018 Planned initiation date changed from 28 Feb 2018 to 8 Mar 2018.
- 22 Jan 2018 Planned End Date changed from 8 Nov 2018 to 18 Dec 2018.
- 22 Jan 2018 Planned primary completion date changed from 8 Nov 2018 to 18 Dec 2018.